8-K: FutureTech II Restates Financials Due to Errors

FutureTech II Acquisition Corp. announced a restatement of previously issued financial statements for multiple periods due to identified errors and misstatements.

Summary

• FutureTech II Acquisition Corp. (the Company) has concluded that its previously issued financial statements for the three and nine months ended September 30, 2024, the year ended December 31, 2024, the three months ended March 31, 2025, and the three and six months ended June 30, 2025, contain errors and misstatements.
• These errors necessitate a restatement of these financial statements, referred to as the Original Financial Statements.
• Specific areas requiring adjustment include earnings per share, common stock subject to redemption due to tax adjustments, and amounts due from the sponsor.
• Consequently, the Company's Quarterly Reports on Form 10-Q for the periods ending September 30, 2024, March 31, 2025, and June 30, 2025, as well as the Annual Report on Form 10-K for the year ended December 31, 2024, should no longer be relied upon.
• The Company intends to amend these reports by filing restated versions within its upcoming Form 10-Q for the quarter ended September 30, 2025, and its Form 10-K for the year ended December 31, 2025.
• A material weakness in internal control over financial reporting has been identified, related to ineffective controls over period-end financial disclosure and reporting processes, including reconciliations and journal entries.
• Remediation measures are being implemented, including engaging a new external advisor and enhancing QuickBooks Online software controls.

Sentiment

Score: 2

Explanation: StockSavvy.ai views this as a significantly negative development due to the widespread nature of the financial statement errors and the identified material weakness in internal controls.

Positives

• The company is proactively addressing identified errors and misstatements in its financial reporting.
• Remediation efforts are underway to strengthen internal controls over financial reporting, including engaging external advisors and enhancing software capabilities.

Negatives

• Previously issued financial statements for multiple periods (Q3 2024, FY 2024, Q1 2025, Q2 2025) are unreliable and require restatement.
• A material weakness in internal control over financial reporting has been identified.
• Disclosure controls and procedures were not effective as of December 31, 2024, and December 31, 2025.

Risks

• Potential for further adjustments during the restatement process.
• The material weakness in internal controls could lead to future misstatements if not effectively remediated.
• Reliance on forward-looking statements carries significant risks and uncertainties that could cause actual results to differ materially.

Future Outlook

The company intends to correct the errors by amending previously filed reports and will provide further details on remediation efforts in its Annual Report on Form 10-K for the year ended December 31, 2025. Forward-looking statements are subject to risks and uncertainties, and actual results may differ.

Management Comments

• The Board of Directors, after discussion with management, concluded that previously issued financial statements contain certain errors and misstatements that must be corrected and restated.
• Management is currently working to determine the specific revisions and modifications required for the restatement.
• The Company's management and the Audit Committee have discussed the matters disclosed in this report with the independent registered public accounting firm.

Industry Context

StockSavvy.ai notes that restatements, particularly those stemming from internal control weaknesses, can erode investor confidence and signal potential underlying operational or financial reporting issues. This is a critical development for a SPAC, as it impacts the reliability of historical data used in investment decisions.

Stakeholder Impact

• Shareholders: Potential loss of confidence due to unreliable financial reporting and identified control weaknesses, which could impact stock valuation.
• Creditors: May require closer scrutiny of financial health and internal controls.
• Investors: Need to disregard previously issued financial statements and await restated figures, creating uncertainty.

Next Steps

• Determine specific revisions and modifications required for the restatement of Original Financial Statements.
• Restate the Original Financial Statements.
• Amend the Q-3 Form 10-Q, 2024 Form 10-K, Q-1 Form 10-Q, and Q-2 Form 10-Q by filing restated versions.
• Continue to design and implement remediation measures to address the material weakness in internal control over financial reporting.
• File the Company's Annual Report on Form 10-K for the year ended December 31, 2025, as promptly as possible, which will detail the remediation plan.

Key Dates

Recommendation

The significant restatement of financial statements and the identification of a material weakness in internal controls warrant a cautious approach. While the company is initiating remediation, the extent of past errors and the time required to fully rectify control deficiencies create substantial uncertainty. Investors should await the restated financials and evidence of effective remediation before considering a more definitive investment stance.

Keywords

8-K, Financial Restatement, Internal Controls, Material Weakness, FutureTech II Acquisition Corp., SEC Filing, Financial Reporting, Earnings Per Share, Common Stock Subject to Redemption